How Emerging Biopharma CMOs Can Better Partner with Patient Organizations

This podcast features a panel discussion from the 2025 Chief Medical Officer Summit 360° with biotech CMOs across indications about how CMOs can better develop drugs patients want and derisk development by partnering with patient organizations. Specifically, the panelists address:Patient voice driving drug development forwardSupporting health equity and patient access after approvalBuilding genuine relationships and engaging early to get to the right patients at the right time and for better advocacy about your researchBuilding a community of awareness and working with patients for support throughout the regulatory processIntegrating the patient perspective in earlyReal world examples and their impactsTo learn more about the Chief Medical Officer Summit 360°, please visit CMO360.org.